Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Maas Biolab LLC
Profile last edited on: 4/11/2016      CAGE: 4GE14      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2001
First Award
2007
Latest Award
2009
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1155 University Boulevard SE
Albuquerque, NM 87106
   (505) 843-4230
   michael@maasbiolab.com
   www.maasbiolab.com
Location: Single
Congr. District: 01
County: Bernalillo

Public Profile

Maas Biolab is a private pharmaceutical company developing Mitogard®, the only cyclosporin formula designed for CSF delivery, to treat ALS. Maas Biolab holds FDA Orphan Drug Designation for cyclosporin to treat ALS and world patents for cyclosporin neuroprotection against chronic neurological diseases

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$1
Phase II Dollars
$2,128,359
Total Awarded
$2,128,360

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2010 2 NIH $2,128,360
Project Title: Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Key People / Management

  Marcus Keep -- Director

  Jenny Karlsson

Company News

There are no news available.